📰 Ivan Oransky News
Ivan Oransky News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ivan Oransky. Real-time updates on events, politics, business and more.
May 30, 2024
Faking it until you make it may be a common practice in some careers. But it's clearly unethical for scientists and medical researchers.
May 29, 2024
Faking it until you make it may be a common practice in some careers. But its clearly unethical for scientists and medical researchers.
May 28, 2024
Faking it until you make it may be a common practice in some careers. But it’s clearly unethical for scientists and medical researchers. All the same thousands of fake papers are churned out by so-called paper mills and published every year, many of them in peer-reviewed journals. The issue made headlines recently when Wiley, a respected publishing house, announced it would be dropping 19 of ...
May 28, 2024
These aren't just papers with fudged data -- they're fake all the way through.
May 27, 2024
A group of whistle-blowers submitted a report to the NIH that questioned the integrity of a celebrated neuroscientist's research and the safety of an experimental stroke treatment his company was developing.
May 27, 2024
NEW YORK (TNS) — Faking it until you make it may be a common practice in some careers. But it’s clearly unethical for scientists and medical researchers. All the same
May 27, 2024
NEW YORK (TNS) — Faking it until you make it may be a common practice in some careers. But it’s clearly unethical for scientists and medical researchers. All the same
May 26, 2024
A group of whistle-blowers submitted a report to the NIH that questioned the integrity of a celebrated neuroscientist's research and the safety of an experimental stroke treatment his company was developing.
May 26, 2024
Fake research papers, churned out by paper mills, are flooding peer-reviewed journals, undermining scientific integrity.
May 25, 2024
A group of whistle-blowers submitted a report to the NIH that questioned the integrity of a celebrated neuroscientist's research and the safety of an experimental stroke treatment his company was developing.